Atrial natriuretic peptide gene delivery attenuates gentamycin-induced nephrotoxicity in rats

Nephrology Dialysis Transplantation

Volumn 14, Issue 6, 1999, Pages 1376-1384

  Murakami, Hideyuki ^a   Yayama, Katsutoshi ^a   Chao, Julie ^a   Chao, Lee ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Adenovirus; Atrial natriuretic peptide; Gene delivery; Gentamycin; Nephrotoxicity

Indexed keywords

ATRIAL NATRIURETIC FACTOR; ATRIAL NATRIURETIC FACTOR DERIVATIVE; CYCLIC GMP; GENTAMICIN; NITROGEN; POTASSIUM; PROTECTIVE AGENT; SODIUM; UREA;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DEATH; CONTROLLED STUDY; FLUID INTAKE; GENE TARGETING; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY BLOOD FLOW; KIDNEY TUBULE DAMAGE; MALE; MICTURITION; NEPHROTOXICITY; NONHUMAN; POTASSIUM EXCRETION; PRIORITY JOURNAL; RAT; SODIUM URINE LEVEL; SUBCUTANEOUS DRUG ADMINISTRATION; UREA NITROGEN BLOOD LEVEL; URINE VOLUME;

ANIMALS; ATRIAL NATRIURETIC FACTOR; BLOOD UREA NITROGEN; CYCLIC GMP; GENE THERAPY; GENTAMICINS; HUMANS; KIDNEY; MALE; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 0033012868     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/14.6.1376     Document Type: Article

References (26)

1. Mathew TH. Drug-induced renal disease. Med J Aust 1992; 156: 724-728
2. Humes HD. Aminoglycoside nephrotoxicity. Kidney Int 1988; 33: 900-911
3. Kacew S, Bergeron MG. Pathogenic factors in aminoglycoside-induced nephrotoxicity. Toxicol Lett 1990; 51: 241-259
4. Hishida A, Nakajima T, Yamada M, Kato A, Honda N. Roles of hemodynamic and tubular factors in gentamicin-mediated nephropathy. Renal Failure 1994; 16(1): 109-116
5. De Bold AJ, Borenstein HB, Veress AT, Sonnenberg, H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci 1981; 28: 89-94
6. Mukoyama M, Nakao K, Hosoda K et al. Brain natriuretic peptide as a novel cardiac hormone in humans: evidence for ab equisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 1991; 87: 1402-1412
7. Chinkers M, Garbers DL. Signal transduction by guanylyl cyclases. Ann Rev Biochem 1991; 60: 553-575
8. Brenner BM, Ballermann BJ, Gunning ME, Zeidel ML. Diverse biological actions of atrial natriuretic peptide. Physiol Rev 1990; 70: 665-699
9. Hollister AS, Inagami T. Atrial natriuretic facftor and hypertension. Am J Hypertens 1991; 4: 850-865
10. Hirata Y, Ishii M, Sugimoto T et al. Hormonal and renal effects of atrial natriuretic peptide in patients with secondary hypertension. Circulation 1988; 78: 1401-1410
11. Lin KF, Chao J, Chao L. Atrial natriuretic peptide gene delivery attenuates hypertension, cardiac hypertrophy, and renal injury in salt-sensitive rats. Human Gene Ther 1998; 9: 1429-1438
12. Lin KF, Chao J, Chao L. Human atrial natriuretic peptide gene delivery reduces blood pressure in hypertensive rats. Hypertension 1995; 26: 847-853
13. Bauer JD. Carbohydrates and nitorgen compounds. In: Bauer JD, ed. Clinical Laboratory Methods (9th ed), The C.V. Mosby Co., St. Louis: 1982: 472-505
14. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-275
15. Lin KF, Chao L, Chao J. Prolonged reduction of high blood pressure with human nitric oxide synthase gene delivery. Hypertension 1997; 30[part 1]: 307-313
16. Murakami H, Yayama K, Chao L, Chao J. Human kallikrein gene delivery against gentamycin-induced nephrotoxicity in rats. Kidney Int 1998; 53: 1305-1313
17. Endlich K, Steinhausen M. Natriuretic peptide receptors mediate different responses in rat renal microvessels. Kidney Int 1997; 52: 202-207
18. Collier VU, Lietman PS, Mitch WE. Evidence for luminal uptake of gentamicin in the perfused rat kidney. J Pharmacol Exp Ther 1979; 210: 247-251
19. Gilbert DN, Houghton DC, Bennett WM, Plamp CE, Reger K, Porter GA. Reversibility of gentamicin nephrotoxicity in ratsl: Recovering during continuous drug administration. Proc Soc Exp Biol Med 1979; 160: 99-103
20. Nouwen EJ, Verstrepen WA, Buyssens N, Zhu HQ, DeBroe ME. Hyperplasia, hypertrophy and phenotypic alterations in the distal nephron after acute proximal tubular injury in the rat. Lab Inv 1994; 70:479-493
21. 125I] α-rat atrial natriuretic peptide binding in microdissected glomeruli and tubules. Pflügers Archiv 1987; 408: 356-365
22. Kudo T, Baird A. Inhibition of aldosterone production in the adrenal glomerulosa by atrial natriuretic factor. Nature 1984; 32: 756-757
23. Johnson CL, Hodsman PG, Kohzuki M, Casley DJ, Fabris B, Phillips PA. Interaction between atrial natriuretic peptide and the renin angiotensin aldosterone system. Am J Med 1989; 87 [Suppl 6B]: 24S-28S
24. Akabane S, Imanishi M, Matsushima Y et al. Renal actions of atrial natriuretic peptide on the postischemic kidney. Can J Physiol Pharmacol 1988; 66: 601-607
25. Schafferhans K, Heidbreder E, Sperber S, Dammrich J, Heidland A. Atrial natriuretic peptide in gentamicin-induced acute renal failure. Kidney Int 1988; 34 [Suppl 25]: S101-S103
26. Ali BH. Gentamicin nephrotoxicity in humans and animals: Some recent research. Gen Pharmacol 1995; 26: 1477-1487